Abstract
Autoimmune Haemolytic Anaemia (AIHA) is a rare yet serious condition characterized by immune-mediated red cell destruction. It presents with anaemia, jaundice, and splenomegaly, requiring a high index of suspicion for timely diagnosis. We present two cases managed at the Kenyatta National Hospital (KNH), highlighting varied disease courses and treatment responses. Management includes corticosteroids as first-line therapy, with immunosuppressants or biologics like rituximab for refractory cases. Limited access to diagnostic tests and treatment options remains a challenge in Kenya. Addressing these barriers through improved clinician awareness and healthcare infrastructure is crucial for optimizing AIHA outcomes in resource-limited settings.
How to cite
Debbie Mwende Mutua, Matilda Ong’ondi (2025). Autoimmune Haemolytic Anaemia: A report of two cases with varied clinical course managed at the Kenyatta National Hospital, Nairobi, Kenya. Journal of Kenya Assocation of Physicians. https://doi.org/10.4314/jkap.v7i2.5
Republished on Discussion Research from the global Crossref scholarly index with full credit to the original authors and African Journals Online (AJOL). Licence: https://creativecommons.org/licenses/by/4.0
